June 21 | 2018
2cureX presenterar positiva kliniska data från den kliniska studien med IndiTreat vid ESMO i Barcelona
Read more
June 21 | 2018
2cureX presents positive clinical data from its IndiTreat® CRC trial at ESMO in Barcelona
Read more
May 24 | 2018
Universitetssjukhuset Rigshospitalet, University Medical Center Hamburg-Eppendorf och 2cureX har inlett en studie avseende äggstockscancer
Read more
May 24 | 2018
The University Hospital, Rigshospitalet, University Medical Center Hamburg-Eppendorf and 2cureX have initiated a clinical study in ovarian cancer
Read more
May 4 | 2018
2cureX publicerar idag en ny informationsbroschyr
Read more
May 4 | 2018
2cureX releases new information brochure
Read more
May 2 | 2018
2cureX’s CEO Ole Thastrup will join Folkemødet 2018 in Denmark
Read more
May 2 | 2018
2cureX:s VD deltar på Folkemødet 2018 i Danmark
Read more
April 24 | 2018
2cureX is expanding its operations in Germany with the opening of a screening lab at Centrum für innovative Medizin (CiM), Hamburg
Read more
April 24 | 2018
2cureX utvidgar sin verksamhet genom att öppna ett screeninglab vid Centrum für innovative Medizin (CiM) i Hamburg
Read more
March 13 | 2018
2cureX receives first payment of EUR 1,5 million from EU Horizon 2020
Read more
March 13 | 2018
2cureX har erhållit första utbetalningen om 1,5 MEUR från Horizon 2020
Read more
March 12 | 2018
2cureX inbjudna att presentera IndiTreat® och klinisk data på ESMO i juni 2018
Read more
March 12 | 2018
2cureX invited to present IndiTreat® and clinical data at ESMO in June 2018
Read more
February 27 | 2018
2cureX deltar på Sedermeradagen Köpenhamn
Read more
February 27 | 2018
2cureX will participate at Sedermeradagen Copenhagen
Read more
January 22 | 2018
2cureX avtalar om de slutliga villkoren gällande ett bidrag om 29 MSEK från Horizon 2020
Read more
January 22 | 2018
2cureX agrees on final terms concerning an EUR 3 million grant from Horizon 2020
Read more